-
Feb 28, 2025 | 
hiv.gov
...
-
Feb 7, 2025 | 
hiv.gov
PrEP, or pre-exposure prophylaxis, is medicine people at risk for HIV take to prevent getting HIV from sex or...
-
Jan 31, 2025 | 
hiv.gov
HIV PEP, or post-exposure prophylaxis, is a short course of HIV medicines taken very soon after a possible exp...
-
Oct 25, 2024 | 
hiv.gov | Bradley Stoner |TB Prevention
Dear Partners in Prevention,I am pleased to report that CDC has awarded funding to the University of Alabama Birmingham and the University of Washington to explore innovative sexually transmitted infection (STI) and HIV prevention strategies: 1) implementation of doxycycline as post-exposure prophylaxis (doxy PEP); and 2) HIV and syphilis point-of-care testing (POCT). This work has been made possible by an investment from the HHS Minority HIV/AIDS Fund (MHAF).
-
Sep 19, 2024 | 
hiv.gov | Monica M. Bertagnolli
Cross-posted from: NIH Office of the DirectorI am pleased to announce the selection of Geri R. Donenberg, Ph.D., as NIH Associate Director for AIDS Research and Director of the NIH Office of AIDS Research (OAR), part of the Division of Program Coordination, Planning, and Strategic Initiatives in the NIH Office of the Director (OD). She will join NIH this October to lead the advancement and coordination of HIV/AIDS research at NIH, working closely with NIH Institutes and Centers.
-
Jun 18, 2024 | 
hiv.gov | James I. MacRae
Content From: James Macrae, MA, MPP, Associate Administrator, Bureau of Primary Health Care, Health Resources and Services Administration, U.S. Department of Health and Human Services••3 min readTopicsThe Health Center Program, funded by the Health Resources and Services Administration’s (HRSA) Bureau of Primary Health Care (BPHC), plays a critical role in the efforts to end the HIV epidemic by providing comprehensive, accessible, and affordable health care to medically underserved populations.
-
Apr 8, 2024 | 
hiv.gov | Neera Tanden
As the President’s Domestic Policy Advisor, I am delighted to announce that Francisco Ruiz has joined our team at the White House as the next Director of the White House Office of National AIDS Policy (ONAP). Accelerating our efforts to end the HIV epidemic in the United States and improve the quality of life for people with HIV remains a critical public health priority for the Biden-Harris Administration.
-
Jan 30, 2024 | 
hiv.gov | Laura Bachmann |TB Prevention
Cross-posted from: Division of STD Prevention| NCHHSTP | CDCCDC’s Annual Report Underscores that STIs Must Be a Public Health PriorityDear Partners in Prevention,Today, CDC released Sexually Transmitted Infections (STI) Surveillance, 2022. The annual report—which highlights that the syphilis epidemic continues to escalate—underscores that STIs must be a public health priority. Overall, in 2022, more than 2.5 million cases of syphilis, gonorrhea, and chlamydia were reported in the United States.
-
Nov 6, 2023 | 
hiv.gov
You can find an HIV test site near you by using HIV.gov s HIV services locator: You can get an HIV test at many...
-
Jun 6, 2023 | 
hiv.gov | Lawrence Tabak
Cross-posted from: NIH Director’s BlogPosted on June 6th, 2023 by Lawrence Tabak, D.D.S., Ph.D.In recent years, we’ve witnessed some truly inspiring progress in vaccine development. That includes the mRNA vaccines that were so critical during the COVID-19 pandemic, the first approved vaccine for respiratory syncytial virus (RSV), and a “universal flu vaccine” candidate that could one day help to thwart future outbreaks of more novel influenza viruses.